The main advantage of this system was that it allowed us to experiment with different administration schemes and monitor the effects on the entire tumor cell population, as reflected in the number of tumorspheres, and on the CSC subpopulation (CD44+CD24-/low), as analyzed by FACS, at the same time. This evidence concerns the gene CD44 and neoplasm.